Safeguarging access to combined oral contraceptives


Safeguarging access to combined oral contraceptives

Resource date: Apr 2022


Guidance Note

From a clinical point of view, the WHO determined the amount of ferrous fumarate used as a placebo in combined oral contraceptives is at a non-therapeutic dose and hence has no clinical relevance as an iron supplement. In line with this, UNFPA, in collaboration with other global procurers, has diversified options of prequalified combined oral contraceptives offered to countries.

Of the 8 combined oral contraceptives UNFPA supplies, only 1 contains the iron placebos, 4 contain non-iron placebos and 3 have no placebos for the 7-day hormone-free period. 

We use cookies and other identifiers to help improve your online experience. By using our website you agree to this. To learn more, including how to change your settings, see our cookie policy